Navigation Links
Prominent Urologist Dr. David B. Samadi Presents Breakthrough Robotic Surgery Techniques on OR Live Webcast
Date:10/30/2008

David B. Samadi, M.D., a world renowned urologic oncologist, discusses his breakthrough robotic surgery techniques, following an OR Live Webcast. His proprietary techniques spare nerves, tissues, and organs responsible for sexual function and continence. To date, Dr. Samadi has performed over 1,500 robotic prostate surgeries and the results are quite pleasing for his patients.

New York, NY (PRWEB) October 30, 2008 -- Dr. David Samadi, Chief of Robotics and Minimally Invasive Surgery at Mount Sinai Medical Center in New York, got into very specific details, with demonstration videos, about conducting robotic surgery during a recent OR-Live webcast. Samadi explained some of his own specialized techniques he's developed from doing more than 1,500 robotic prostatectomies.

One of the great advantages of robotic surgery, according to Dr. Samadi, is nerve sparing. Nerve sparing is crucial for retaining sexual function since severing or damaging the cavernous nerves causes erectile dysfunction. These nerves course laterally along the prostate and rectum and provide nerve connections to the proximal penis deep in the pelvis. If they are damaged, erectile function is, too. Put simply, preserving the cavernous nerves preserves sexual potency. There are treatments for erectile dysfunction resulting from radical prostatectomies but every patient, of course, wants to retain natural sexual function after prostate surgery.

The robotic surgery technique inadvertently spares the nerves responsible for sexual function as well as continence. Since there is no blood in the operation field in robotic surgery, D
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4

Related biology technology :

1. Prominent Physician Achieves Success Using Topical Sinus Medications via Pulsitile Irrigation
2. Radiesse(R) Dermal Filler Featured Prominently in Journal of Dermatologic Surgery Special Issue on Fillers
3. Boston Scientifics SpyGlass(R) Direct Visualization System to Be Prominently Featured at Digestive Disease Week(R)
4. PercSys Names David Auth and Howard Palefsky to Its Board of Directors
5. David H. Murdock Research Institute Taps Waters for Laboratory Technology
6. Pacira Pharmaceuticals, Inc. Adds Experienced Physician Dr. David St. Peter to Leadership Team
7. Lumiphore Partners with Biophor Diagnostics, Inc. to Develop Tests for Drugs of Abuse; Appoints Ibis Biosciences Founder David J. Ecker to Board
8. David Hsia, Ph.D. Joins Kinex Pharmaceuticals Board of Directors
9. Trusted LASIK Surgeons Welcomes Leading LASIK Eye Surgery Expert, Inventor David Huang, M.D., Los Angeles, to Its Unique Lasik Directory Service
10. Encorium Appoints David Ginsberg President and Chief Executive Officer, Announces Changes to the Board of Directors
11. [video] David Brown, President and CEO of LifeVantage Corporation, Discusses Record Page Views on WallSt.nets 3-Minute Press Show

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Prominent Urologist Dr. David B. Samadi Presents Breakthrough Robotic Surgery Techniques on OR Live Webcast
Prominent Urologist Dr. David B. Samadi Presents Breakthrough Robotic Surgery Techniques on OR Live Webcast
(Date:11/7/2009)...v. 7, Research projects in the are...s this evening, as Tim Kunisky of Livingston, NJ a...of Audubon, PA received the highest honors at the ... in Math, Science & Technology, the nation,s p...ttp://www.newscom.com/cgi-bin/prnh/20070904/SIEMEN...
(Date:11/6/2009).... 6 Helix BioPharma Corp...ounced that John Docherty, president and chief ope...rd,s 6th annual Investor Summit on November 10, 20...y. Mr. Docherty will provide an overview of the C...S47 and Topical Interferon Alpha-2b. The slide sh...
(Date:11/6/2009)...ov. 6 ,, 3Q09 Corp...utenza(TM) E.U. Marketing Authorization to Astella...n commercial readiness activities Expanded manage...rketing; and Director, Commercial Operations Appo... Audit Committee chairman , Upcoming 2009 M...
(Date:11/6/2009).... 6 Intarcia Therapeutics, Inc. de...UROS® continuous delivery of exenatide) progr...th Annual Diabetes Technology Meeting in San Franc...-bin/prnh/20050301/SFTU126LOGO ) ,, Continuou...Lowers Plasma Glucose, HbA1c and Reduces Weight in...
Breaking Biology Technology:Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 2Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 3Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 4Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 5Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 6Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5
...ewswire/ -. Actavis Group, the,international gener...t has,received approval from the U.S. Food & Drug ...em. Distribution of the product will begin,immedia...equivalent of Alza/Janssen,s,Duragesic(R) and avai...ntanyl Transdermal System is indicated for the man...
...otechnology Company confirms commercial expression... status of native Apo AI -, CALGARY, Aug. 22 /PRN...SBS), a biotechnology company developing a portfol...ovascular diseases, today updated a release,issued...achieved commercial,levels of apolipoprotein AI (n...
...epublic, Aug. 21 Medpace,Inc., a leading global f...announced it has completed the acquisition of Mona...n (CRO) headquartered in Prague, Czech,Republic. T...al Europe and,expands its capacity to provide full...zech Republic and Slovakia. Petr Potuznik, MD, the...
Other Biology Technology:Actavis Receives Approval of Fentanyl Transdermal System in the U.S. 2SemBioSys updates Apo AI development program 2SemBioSys updates Apo AI development program 3SemBioSys updates Apo AI development program 4Medpace Strengthens Presence in Central Europe 2
(Date:11/4/2009)..., PORTOLA VALLEY, Calif., Oct. 19 ...olecular sensing and imaging devices which shed li...that it has signed exclusive distribution deals fo...nsors. The markets covered include Australia, New...enelux), Suriname, Italy, France, Spain, Portugal,...
(Date:11/4/2009)..., RIDGE, N.Y., Oct. 21 What,s the ...eventing accidental death resulting from prescript...s with good intentions, however, may be unaware th...ting their teens from the ticking timebomb of pres...leader in premium-quality medical supplies, has fo...
(Date:11/4/2009)..., CHAPEL HILL Scientists at the University of ...nd the University of California, San Francisco hav...to predict new target diseases for existing drugs....hod that compares how similar the structures of al...ng partners -- known as ligands -- of disease targ...
Breaking Biology News(10 mins):Spectros Signs New International Distribution Deals 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3Study points to new uses, unexpected side effects of already existing drugs 2NSF Emerging Frontiers program supports development of smart materials based on study of fish 9613 1NSF Emerging Frontiers program supports development of smart materials based on study of fish 9613 2NSF Emerging Frontiers program supports development of smart materials based on study of fish 9613 3Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting 54852 1Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting 54852 2Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting 54852 3Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting 54852 4Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting 54852 5Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting 54852 6Martek to Announce Third Quarter 2009 Results 13629 1
...A study has found that the risks of a premature bi...ast two trimesters of pregnancy. The research was ...t de Montral,s Faculty of Pharmacy and the Sainte-...ent Krystel Moussally. , In Canada, 50 percent o... many of them prefer to use natural health product...
... The Aplastic Anemia & MDS International Foundatio...Committee for Medicinal Products for Human Use (CH...inion for the treatment of myelodysplastic syndrom...ll transplants. , The CHMP,s positive opinion is...strated an overall, unprecedented survival benefit...
... Construction of the brain,s border fence is super...t al. in The Journal of Cell Biology ., Like many...security to maintain levels of nutrients and keep ... is a virtually impermeable network of tight junct...ellular flow of materials. Because Wnt/b-catenin s...
Other Biology News:
Mouse Anti-Human p53, wild & mutant, aa 19-26 Monoclonal Antibody, Unconjugated, Clone DO-7 from CHEMICON
Tube-O-DIALYZER Floats, Floats, Small from CHEMICON
Anti-Feline Rhinotracheitis Virus Monoclonal Antibody, Unconjugated from ViroStat Inc.
Anti-Ezrin / Radixin / Moesin Antibody, Unconjugated from Cell Signaling Technology
Biology Products: